Hans E Grossniklaus
Overview
Explore the profile of Hans E Grossniklaus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
331
Citations
5338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Modgil S, Walker C, Chrenek M, Grossniklaus H, McDonald F, Iuvone P
bioRxiv
. 2025 Mar;
PMID: 40027732
Brain-derived neurotrophic factor (BDNF) signaling through the tropomyosin-related kinase B (TrkB) receptor promotes neuronal growth and survival following an injury. However, its short half-life and pleiotropic effects limit the clinical...
2.
Highfield H, Tenkman L, Grossniklaus H
Ophthalmology
. 2025 Feb;
PMID: 39969448
No abstract available.
3.
Shelton D, Papania J, Getz T, Sellers J, Giradot P, Chrenek M, et al.
bioRxiv
. 2024 Dec;
PMID: 39679905
Purpose: Pigment epithelium-derived factor (PEDF) is a neurotrophic glycoprotein secreted by the retinal pigment epithelium (RPE) that supports retinal photoreceptor health. Deficits in PEDF are associated with increased inflammation and...
4.
Starrett G, Baikie B, Stoff B, Grossniklaus H, Van Buren I, Berry E, et al.
Clin Cancer Res
. 2024 Sep;
30(21):4887-4899.
PMID: 39287419
Purpose: Sebaceous carcinoma is the third most common nonkeratinocyte skin cancer in the United States with 1,000 cases per year. The clinicopathologic features of sebaceous carcinoma and benign sebaceous neoplasms...
5.
Choo C, Cote O, Bostwick K, Regueiro M, Wells J, Grossniklaus H, et al.
Br J Ophthalmol
. 2024 Aug;
109(1):70-75.
PMID: 39122354
Purpose: To compare the diagnostic utility of metagenomic deep sequencing (MDS) to cytology, flow cytometry and gene rearrangement by PCR in ocular samples of patients with suspected vitreoretinal lymphoma (VRL)....
6.
Seigel G, Onwumere O, Sauane M, Lopez S, Shang E, Habiba H, et al.
Pathol Res Pract
. 2024 Jun;
260:155392.
PMID: 38880039
In this study, we tested the hypothesis that ALYREF/THOC4, a poor prognostic factor in different cancer types, has potential as a drug target and prognostic biomarker for retinoblastoma (RB). Immunostaining...
7.
Fard M, Chan J, Read A, Li G, Cheng L, Safa B, et al.
bioRxiv
. 2024 May;
PMID: 38798683
One Sentence Summary: A novel magnetic cell therapy provided effective intraocular pressure control in a mouse model of glaucoma, motivating future translational studies.
8.
Joseph S, Pike S, Peng C, Brown B, Xu L, Berry J, et al.
Ocul Oncol Pathol
. 2024 May;
10(1):15-24.
PMID: 38751495
Introduction: The objective of this study was to report the clinicopathologic features of three cases of -amplified retinoblastoma identified genetically by aqueous humor sampling. Methods: Whole-genome sequencing was performed using...
9.
Milman T, Grossniklaus H, Goldman-Levy G, Kivela T, Coupland S, White V, et al.
Ocul Oncol Pathol
. 2023 Oct;
9(3-4):71-95.
PMID: 37900189
No abstract available.
10.
Eder A, Milman T, Mudhar H, Lally S, Shields C, Bui K, et al.
Surv Ophthalmol
. 2023 Oct;
69(2):230-240.
PMID: 37890676
Indeterminate melanocytic proliferations of the conjunctiva have both benign and malignant features that previously made these lesions nearly impossible to categorize in existing classification schemes. With the evolution of immunohistochemistry...